SECURITIES (DISCLOSURE OF INTERESTS) DAILY SUMMARIES - (GEM)                         PRINTED: 09/10/00  PAGE:   1
                                                        DIRECTORS'/CHIEF EXECUTIVES' NOTIFICATIONS REPORT - B
                                                            (GRANTS, ASSIGNMENTS AND EXERCISES OF RIGHTS)

 STOCK NAME : Sino Biopharm                  (08027)

       Director/Chief Executive        G/E     Class                 Company Name                 Quantity       Exercise Period   Ex. Price  Consideration
 ------------------------------------  --- ---------------  -------------------------------  ------------------  ---------------  ---------- ---------------
 TSE PING                               E  ORD              SINO BIOPHARMACEUTICAL LIMITED          9,000,000 N1        -              -                   0

                                                                     *****  END OF REPORT  *****

Note:


N1     9,000,000 shares were borrowed by DBS Asia Capital Limited under stock
       borrowing arrangement for settlement of over-allocation in connection
       with placing on initial listing of the Company.